Practical Aspects of the Development ofex Vivoandin VivoGene Therapy for Parkinson's Disease

Author： Bankiewicz K.S. Leff S.E. Nagy D. Jungles S. Rokovich J. Spratt K. Cohen L. Libonati M. Snyder R.O. Mandel R.J.

Publisher： Elsevier

ISSN： 0014-4886

Source： Experimental Neurology, Vol.144, Iss.1, 1997-03, pp. : 147-156

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Application ofex VivoGene Therapy in the Treatment of Parkinson's Disease

By Raymon H.K. Thode S. Gage F.H.

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 82-91

Elsevier

Access to resources Recommend Favorite

In Vivo Adenovirus-Mediated Gene Transfer for Parkinson's Disease

By Horellou P. Bilang-Bleuel A. Mallet J.

Neurobiology of Disease, Vol. 4, Iss. 3, 1997-03 ,pp. : 280-287

Academic Press

Access to resources Recommend Favorite

From Transplants to Gene Therapy for Parkinson's Disease

By Freeman T.B.

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 47-50

Elsevier

Access to resources Recommend Favorite

Dopamine Synthesis, Uptake, Metabolism, and Receptors: Relevance to Gene Therapy of Parkinson's Disease

By Elsworth J.D. Roth R.H.

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 4-9

Elsevier

Access to resources Recommend Favorite

Targets for Gene Therapy of Parkinson's Disease: Growth Factors, Signal Transduction, and Promoters

By During M.J. Leone P.

Experimental Neurology, Vol. 144, Iss. 1, 1997-03 ,pp. : 74-81

Elsevier

Access to resources Recommend Favorite